跳至主要内容
临床试验/IRCT20201015049030N2
IRCT20201015049030N2招募中未知

Comparison of the efficacy and possible side effects of high and standard doses of rifampin in the treatment of brucellosis, a randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 no limit(—)
性别
All

入选标准

  • Isolation of Brucella in culture of blood or bone marrow or other body fluids
  • Positive Brucella PCR test in blood and / or body fluids or tissue samples
  • Wright title equal to or greater than 160/1
  • The title of Combs Wright is at least two levels higher than Wright

排除标准

  • Age less than 14 years-
  • Intrinsic or acquired immunodeficiency
  • Simultaneous with advanced or chronic heart, lung, liver and kidney diseases
  • Pregnancy-
  • Taking oral contraceptives
  • Consumption of phenytoin
  • History of receiving anti-brucellosis treatment in a recent month for more than a week
  • Infection with local forms of malaria, endocarditis, spondylitis, meningitis, etc.
  • Taking antibiotics more than 7 days before the visit
  • History of allergy to doxycycline or rifampin
  • General malaise so that the patient is not able to take medication orally.

研究者

相似试验

Comparison of the efficacy and possible side effects... | 临床试验